Chirag K. Patel Receives Stock Award at Amneal Pharmaceuticals Inc (AMRX) — SEC Form 4, Mar 07, 2023

SEC Form 4 · No Market Transaction
Stock Award

Compensation grant — no market purchase or sale.

Reporting Owner
Chirag K. Patel
CEO 10% Owner
TXN 2023-03-03 · FILED 2023-03-07
Filing Lag 2 business days within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership

Amneal Pharmaceuticals Inc

AMRX CIK 0001723128
All Amneal Pharmaceuticals Inc insider activity
Filing Date
2023-03-07
Report Date
2023-03-03
Accession No.
0001209191-23-016930
Accepted At
2023-03-07 23:00 UTC
Reporting Owner
Name Relationship
Chirag K. Patel CIK 0001738701
Director CEO 10% Owner
Chirag K. Patel at Amneal Pharmaceuticals Inc Full insider history
Bought (12 mo) —
Sold (12 mo) —
More from this insider at Amneal Pharmaceuticals Inc
2026-08-12 Award — View
2026-03-05 Exercise — View
2026-03-03 Award — View
2025-03-06 Exercise — View
2024-03-06 Award — View
All filings by this insider at Amneal Pharmaceuticals Inc
Derivative Securities Transactions
Title Strike Date Type Shares Price Expiration Underlying Ownership
Performance-Based Restricted Stock UnitsF1F2F2F2F2F2 2023-03-03 A - Award/Grant 733,944 A $0.00 733,944 Class A Common Stock Direct
Footnotes (2)
F1
Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Show more
F2
Represents a performance-based restricted stock unit grant of 366,972 target shares. The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing price per share targets at the end of the three-year performance period. The number of shares that would be received upon vesting, if any, may vary from 0% to 200% of the target number. The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award. Any earned performance-based restricted stock units vest in full on February 28, 2026, the last day of the performance period. Show more

Related filings at Amneal Pharmaceuticals Inc

Institutional Holders
13F holders · Jun 30, 2026 312 institutional managers reporting a position
Largest by reported value
  1. Black Rock, Inc. $460M
  2. Tpg Gp A, Llc $213M
  3. Vanguard Portfolio Management Llc $210M
5%+ Holders · 13D/G 6 filers

Latest Schedule 13D/G per filer; stakes the filer reported closed are left out.

Other insiders at Amneal Pharmaceuticals Inc
All Amneal Pharmaceuticals Inc insider activity
GET /v1/forms/4/0001209191-23-016930 API docs
View Original SEC Filing